Why Fluidigm Stock Plunged Today

Shares of Fluidigm (NASDAQ: FLDM) plummeted on Thursday after a powerful rival announced a major development in the COVID-19 diagnostic race.

What a difference a day makes. After soaring 30% on Wednesday following news that its saliva-based coronavirus test had received an emergency use authorization from the U.S. Food and Drug Administration (FDA), Fluidigm gave up all of those gains today.

Fluidigm's stock made a round trip over the past two days. Image source: Getty Images.

Continue reading

Source Fool.com